Clinical Trial Detail

NCT ID NCT02881242
Title Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

prostate cancer

Therapies

Trametinib

Age Groups: adult senior

No variant requirements are available.